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A B S T R A C T
Objectives: Willis–Ekbom disease/restless legs syndrome (WED/RLS) is the most common sleep-related
movement disorder in pregnancy. We designed a prospective longitudinal study to investigate the cor-
relates of WED/RLS during and after pregnancy.
Design: A total of 138 pregnant women with WED/RLS and a control group of 251 age-matched preg-
nant womenwere enrolled prospectively. A questionnaire was administered during a face-to-face interview
at ﬁrst evaluation during pregnancy and three months after delivery.
Results: Among all women in the ﬁrst trimester, 15.6% were diagnosed with WED/RLS, whereas 32.8%
of those in the second trimester and 38.8% of those in the third trimester were diagnosed with WED/
RLS (p = 0.032). In regression analysis, later gestational age [p < 0.001; odds ratio (OR) 1.054] and previous
history of WED/RLS (p = 0.001; OR 2.795) were positively correlated with the presence of WED/RLS, while
ferritin levels (p = 0.001; OR 0.956) were negatively correlated with the presence of WED/RLS. Ferritin
levels were also negatively correlated with the International RLS Study Group severity index (p = 0.041).
Forty-eight patients (34.8%) experiencedWED/RLS symptomatology after delivery. The ferritin levels were
lower, and the mean number of pregnancies was higher, in women with residual WED/RLS (p = 0.008).
Conclusion: Our survey showed that WED/RLS was more common in the second and third trimesters.
Emergence of WED/RLS during the second trimester was strongly associated with residualWED/RLS. Lower
ferritin levels were associated with both WED/RLS in pregnancy and residual WED/RLS after delivery. A
higher number of pregnancies were also associated with a greater likelihood of having residual WED/
RLS after delivery.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Willis–Ekbom disease/restless legs syndrome (WED/RLS) is a
common sleep-related movement disorder with a prevalence of up
to 10% in the general population [1]. In most epidemiological studies
based on International Restless Legs Syndrome Study Group (IRLSSG)
criteria, the prevalence of WED/RLS has been demonstrated to be
about one and a half to two times greater in women [2]. It has been
suggested that this gender difference may be related to the differ-
ences in either iron deﬁciency or hormone status [3]. The increased
prevalence of WED/RLS in pregnant women has prompted
investigations into the relevance of female hormones, particularly
the increased levels of estrogen found during late pregnancy [4,5].
Indeed, appearance or exacerbation of pre-existingWED/RLS symp-
toms during pregnancy has been reported by IRLSSG criteria-
based surveys. The prevalence of WED/RLS during pregnancy is
around three times greater than in the general population and is
reported to vary between 15 and 35% [5–8]. It also shows a ten-
dency to be more severe during this period [5,8].
However, factors related to the occurrence of WED/RLS in preg-
nant women are not well known. It has been suggested that the
increased prevalence of WED/RLS associated with pregnancy may
be related to iron deﬁciency and hormonal changes during this period
[8–10]. On the other hand, well-designed studies have failed to ﬁnd
evidence that female hormones, or iron, and/or folate deﬁcien-
cies, play a major role in the occurrence of WED/RLS during
pregnancy, or have shown inconsistent results [4,5,10,11]. On this
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basis, a prospective longitudinal study was designed with the aim
of investigating the correlates of WED/RLS during and after
pregnancy.
2. Methods
2.1. Population and setting
A total of 138 pregnant women who had been diagnosed as
having WED/RLS at any stage of their pregnancies and were aged
18 years or older were enrolled prospectively into the study. The
study population was formed from the pregnant women attend-
ing routine prenatal oﬃce visits at the Gaziantep Cengiz Gökçek
Obstetrics and Gynecology Hospital in Gaziantep city and at the Is-
tanbul University CerrahpasaMedical Faculty in Istanbul city, Turkey.
Both of these clinics provide public services and have separate fa-
cilities for high-risk pregnancies. Study participants were only
recruited from among those who attended these facilities for women
and had no potential maternal or fetal risk. Women with eclamp-
sia, preeclampsia, or other gestational complications that might favor
or trigger WED/RLS symptoms were excluded, while women with
other known causes of symptomatic WED/RLS were not. A control
group of 251 age-matched pregnant women was also prospective-
ly enrolled. The participants were not recruited consecutively, but
women attending these clinics were evaluated for one year, on two
days per week, and those whomet the inclusion criteria and agreed
to participate in the study were prospectively recruited. The study
was approved by Gaziantep Clinical Research Ethical Committee. All
participants were informed about the nature of the research, and
informed consent was obtained from every participant.
2.2. Study procedure
Questionnaires were administered during face-to-face inter-
views conducted by three clinicians with training in the diagnosis
of WED/RLS (MN, RA and FB). Participants were interviewed re-
gardless of the period of pregnancy, with a cross-sectional approach.
Each interview lasted for about 30 min. All problems regarding the
diagnosis were then discussed with the senior authors (AN and DK).
The clinical-diagnostic interviewwas conducted in accordance with
the criteria deﬁned by the International RLS Study Group (IRLSSG),
and the severity of WED/RLS was assessed using the IRLSSG criteria
[3,12].
The questionnaire consisted of 50 questions, which included:
(1) demographic characteristics such as age, height, body weight,
education, income, number of previous pregnancies, gestational age
for the current pregnancy; (2) habitual behaviors such as current
or past history of smoking, alcohol intake, use of iron or other vitamin
supplements; (3) past medical history, including the past medical
records of the participants; and (4) detailed characteristics of WED/
RLS, if present, such as disease duration, triggering factors, family
history or use of WED/RLS treatment.
Blood samples were collected from all participants and were in-
vestigated to obtain the complete blood count, fasting glucose, blood
ureanitrogen, creatine, ferritin, transferrin saturation, total ironbinding
capacity, urine analysis for albuminuria, and the level of estradiol.
All pregnant womenwithWED/RLS underwent a follow-up face-
to-face interview three months after parturition, which was
conducted by the same clinicians. Women who reported the pres-
ence of WED/RLS at the third postpartum month were questioned
again at six months.
2.3. Statistical analysis
Statistical Package for the Social Sciences (SPSS) version 15.0 for
Windows was used for the statistical analysis. Descriptive variables
were expressed as percentages for categorical variables, and as
mean ± SD for continuous variables. The Chi-squared test was used
in the comparisons of independent categorical variables. St-
udent’s t-test was used to compare themeans of continuous variables
with normal distribution; and the Mann–Whitney U test was used
in the comparisons of continuous variables without normal distri-
bution. Pearson’s correlation, logistic regression or analysis of
variance analysis (ANOVA) were used to analyze risk factors and in-
teractions between non-parametric and parametric variables. The
Bonferonni correction test was applied for multiple comparisons.
The measure of association that was used was OR with 95% CI. All
calculated p-values were two-tailed and considered to be statisti-
cally signiﬁcant if equal to or less than 0.05.
3. Results
A total of 138 pregnant women diagnosed with WED/RLS had
a mean score on the IRLSSG scale of 18.5 ± 6.0 points. According to
the gestational age, seven pregnant women (5.2%) were in the ﬁrst
trimester, 40 women (28.9%) were in the second trimester, and 91
women (65.9%) were in the third trimester. Among all women in
the ﬁrst trimester, 15.6% were diagnosed with WED/RLS, whereas
32.8% of those in the second trimester and 38.8% of those in the third
trimester were diagnosed with WED/RLS (p = 0.032). Symptoms of
WED/RLS had emerged for the ﬁrst time during the current preg-
nancy in 106 women (76.8%, 106/138); 29 of these pregnant women
(27.4%, 29/106) were experiencing their ﬁrst pregnancies. The
number of pregnancies did not show a statistically signiﬁcant re-
lationship with the presence of WED/RLS (p = 0.749, Mann–Whitney
U test). Twenty-three women (16.6%, 23/138) stated that they had
had similar symptoms of WED/RLS during their previous pregnan-
cies, but they were all free of symptoms between pregnancies. Only
nine women (6.5%, 9/138) had symptoms of WED/RLS before preg-
nancy; all of whom had a previous diagnosis of WED/RLS. About
33.6% of pregnant women with WED/RLS reported that tiredness
exacerbated their WED/RLS symptoms, and 10.5% reported stress
as a triggering factor. Other than walking and/or leg movements re-
lieving the symptoms of WED/RLS, which was the case in all women,
leg massage (44.3%) and washing the legs with hot (14.8%) or cold
water (12.0%) were also stated as relieving maneuvers.
The comparison of the pregnant women with and withoutWED/
RLS is shown in Table 1. The mean age of the pregnant women in
both groups was similar, although the mean gestational age was
higher in women with WED/RLS (28.3 ± 8.7 vs 25.9 ± 9.7 weeks,
p = 0.022). All other demographic variables were similar between
the two groups.
Among the pregnant women with WED/RLS, 79.0% had noctur-
nal leg cramps, while 31.1% of the pregnant women without WED/
RLS had nocturnal leg cramps (p < 0.001). Varicose veins were present
in 26.8% of the women with WED/RLS, vs 17.9% of those without
(p = 0.040). Rheumatoid complaints were reported in 6.5% of the
pregnant women with WED/RLS and 2.8% of those without WED/
RLS (p = 0.076). Only one pregnant woman with WED/RLS had
peripheral neuropathy (0.7%), and none of women without WED/
RLS reported peripheral neuropathy. A family history of WED/RLS
was present for 8.7% of the women with WED/RLS, but for 2.5% of
those without (p = 0.006).
Most of the study population had between six and eight hours
of sleep per night: 46.4% among women with WED/RLS and 47.8%
amongwomenwithoutWED/RLS. Having less than six hours of sleep
per night was reported by 28.9% of womenwithWED/RLS and 22.3%
of women without WED/RLS (p = 0.470). Mean subjective sleep
latency was also longer in pregnant women with WED/RLS: 47.1%
of women with WED/RLS (compared with 31.1% of those without
WED/RLS) reported that it took them more than 30 minutes to fall
asleep (p = 0.005).
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The laboratory investigations are summarized in Table 2. Mean
blood urea nitrogen (p = 0.040), ferritin (p = 0.010) and mean trans-
ferrin saturation levels (p = 0.004) were signiﬁcantly lower in women
with WED/RLS (Fig. 1). Other measures were similar between the
two groups.
All of the demographic and laboratory variables were evalu-
ated in the regression analysis. Among them, later gestational age
(p < 0.001, OR 1.054 [1.024–1.084 95% CI OR]) and previous history
of WED/RLS (p = 0.001, OR 2.795 [1.560–5.005 95% CI OR]) were
positively correlated with the presence of WED/RLS, whereas fer-
ritin levels (p = 0.001, OR 0.956 [0.932–0.980 95% CI OR]) were
negatively correlated with the presence of WED/RLS. Ferritin levels
were also negatively correlated with the IRLSSG severity index
(p = 0.041, linear regression analysis and ANOVA). Comparison of
women with WED/RLS that recurred during their pregnancies
(n = 23) and those who experienced WED/RLS symptoms continu-
ously (n = 9) showed that ferritin levels were lower in those with
continuous WED/RLS, although not signiﬁcantly (24.4 ± 16.1 ng/mL
vs 21.6 ± 15.8 ng/mL, p = 0.167).
Follow-upexaminations threemonths after parturition,with face-
to-face interviews conducted by the same clinicians, revealed that
48 women (34.8%) still experiencedWED/RLS symptoms. Of these,
ninewomen hadWED/RLS continuously (18.7%, 9/48), fourwomen
had had WED/RLS temporarily during their previous pregnancies
(8.3%, 4/48), and35women (70%)were experiencingWED/RLS symp-
toms for the ﬁrst time in their lives. Twenty-seven out of the latter
35 women had symptoms that started during the second trimester
(77.1%). Among these 35women, 19wereprimiparous (54.2%, 19/35),
while 16 hadhadmore than onepregnancy (45.8%, 16/35). Themean
number of pregnancies was higher in women with residual WED/
RLS symptoms (4.0 ± 1.4 between three and six pregnancies) when
comparedwith thosewith no symptoms following delivery (2.2 ± 1.1
between one and four pregnancies, p = 0.050). The mean gesta-
tional age for women with residual WED/RLS was also higher than
in those with no residual symptoms (32.0 ± 9.2 vs 29.4 ± 7.5 years),
but this differencewas not signiﬁcant (p = 0.434). Ferritin levelswere
signiﬁcantly lower inwomenwith residualWED/RLS symptomswhen
comparedwith those with no residual symptoms (13.7 ± 7.0 ng/mL
vs 28.6 ± 10.4 ng/mL, p = 0.008) (Fig. 1). All other demographic and
laboratory data, including estradiol levels, failed to show statisti-
cally signiﬁcant differences between the two groups.
4. Discussion
Willis–Ekbomdisease/restless legs syndrome is themost common
movement disorder of pregnancy. The appearance of symptoms is
most commonly reported in the last trimester of gestation [2,8] and
has been reported to generally disappear in the month following
delivery [4,7]. In a Brazilian study [8], 94.4% of pregnantwomenwith
WED/RLS were in the second or third trimester. An earlier onset of
WED/RLS during pregnancy, around the 20th week, has also been
reported [13]. The present survey replicated the ﬁnding that WED/
RLS usually started by the second trimester of pregnancy and was
more common in the second and third trimesters. In addition, it was
observed that the emergence of WED/RLS symptoms during the
second trimesterwasassociatedwith residualWED/RLSafterdelivery.
A follow-up study performed about 6.5 years after delivery
showed that womenwho had transientWED/RLS during their preg-
nancy had a four-fold increased risk of developing chronic WED/
RLS [14]. Another recent study reported that 38.5% of pregnant
women who experienced symptoms for the ﬁrst time during the
index pregnancy developed chronic WED/RLS [6,14]. In the present
study, 34.8% of pregnant women still experienced WED/RLS symp-
toms after parturition; 70% of these were experiencing WED/RLS
symptoms for the ﬁrst time in their lives, and half of them were
multiparous. Studies have reported conﬂicting results as to whether
the number of pregnancies is a risk factor for WED/RLS [6,7,15].
Berger et al. reported data from a large epidemiological study
showing that parous women had a signiﬁcantly greater preva-
lence of WED/RLS than nulliparous women, and that nulliparous
women had the same incidence ofWED/RLS asmen [15]. The present
study found that the number of pregnancies did not show a sta-
tistically signiﬁcant relationship with the presence of WED/RLS; on
the other hand, the mean number of pregnancies was higher for
women with residual WED/RLS symptoms after delivery.
Table 1
Comparison of descriptive variables between women with and without Willis–
Ekbom disease/restless legs syndrome.
Demographic variables Women with
Willis–Ekbom
disease/restless
legs syndrome
(n = 138)
Women without
Willis–Ekbom
disease/restless
legs syndrome
(n = 251)
p
Age
(years, mean ± SD)
27.8 ± 5.8 27.9 ± 6.0 0.854
Age groups,
years, n (%)
15–19 14 (10.4) 20 (8.1) 0.442
20–29 62 (45.9) 130 (52.4)
30–39 59 (43.7) 98 (39.5)
Education,
years, n (%)
None 10 (7.2) 11 (4.4) 0.630
<8 years 74 (53.6) 137 (54.6)
8–12 47 (34.1) 83 (33.0)
>12 7 (5.1) 20 (8.0)
Current or previous
smoking history,
n (%)
14 (10.1) 18 (7.2) 0.307
Use of iron or other
vitamin supplements,
n (%)
104 (75.3) 175 (69.7) 0.073
Current BMI, kg/m2
(mean ± SD)
27.6 ± 4.4 27.4 ± 4.3 0.803
Gestational history
Gestational week
(mean ± SD)
28.3 ± 8.7 25.9 ± 9.7 0.022*
Current pregnancy
number, median
(min–max)
3 (1–13) 2 (1–8) 0.065
Number of previous
children, median
(min–max)
1 (0–6) 1 (0–6) 0.970
Number of abortions,
n (%)
28 (20.4) 40 (15.9) 0.265
* p-value <0.05 indicates statistical signiﬁcance.
Table 2
Comparison of laboratory variables between women with and without Willis–
Ekbom disease/restless legs syndrome.
Laboratory variables Women with
Willis–Ekbom
disease/restless
legs syndrome
(n = 138)
Women without
Willis–Ekbomq
disease/restless
legs syndrome
(n=251)
p
Fasting glucose (mg/dL),
mean ± SD
82.7 ± 16.8 80.9 ± 18.9 0.265
Blood urea nitrogen (mmol/L),
mean ± SD
10.5 ± 5.2 12.0 ± 6.1 0.040*
Creatinine (mg/dL), mean ± SD 0.5 ± 0.09 0.5 ± 0.1 0.468
Ferritin (ng/mL), mean ± SD 17.5 ± 33.4 23.0 ± 19.0 0.010*
Transferrin saturation (%),
mean ± SD
23.3 ± 15.2 52.9 ± 29.2 0.004*
Total iron binding capacity
(μg/dL), mean ± SD
438.1 ± 64.6 421.9 ± 66.7 0.161
Hemoglobin (g/dL), mean ± SD 11.8 ± 1.2 12.4 ± 8.5 0.590
Hematocrit (%), mean ± SD 35.5 ± 3.3 35.9 ± 3.7 0.242
Presence of albuminuria, n (%) 25 (18.1) 36 (14.5) 0.344
Estradiol levels (pg/mL),
mean ± SD
4446.7 ± 5728.6 4532.4 ± 6185.9 0.154
* p-value <0.05 indicates statistical signiﬁcance.
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Among other demographic factors, no difference between preg-
nant women with and without WED/RLS was reported in previous
studies for age, ethnicity or education [7,13]. In the present study,
mean gestational age was signiﬁcantly higher in women withWED/
RLS; it was also higher in those with residualWED/RLS than in those
with remission, although not signiﬁcantly.
A positive family history has been reported as one of the pre-
dictors of WED/RLS in pregnancy, as has the occurrence of WED/
RLS in a previous pregnancy [13,15]. In the present study, a family
history of the conditionwas also signiﬁcantlymore common in preg-
nant women with WED/RLS. However, a family history of WED/
RLS was not signiﬁcantly associated with the presence of residual
WED/RLS symptoms after delivery.
There are different hypotheses for the higher prevalence ofWED/
RLS in pregnancy. Among them, associations with hormone levels,
such as estrogen alterations, andmetabolic changes, such as iron de-
ﬁciency, havebeen investigated inmany studies. In the third trimester
of gestation, elevated levels of estradiol,which counteracts the action
of dopamine, occur at the core time for development of the patho-
physiology of transientWED/RLS in pregnancy [10]. However, many
analyses have failed to show signiﬁcant differences in estrogen levels
between pregnant women with and those without WED/RLS, chal-
lenging the hypothesis that estrogen levels may play an important
role in the pathophysiology of WED/RLS in this context [13]. In the
present study, estradiol levels were also similar between pregnant
womenwith and those withoutWED/RLS. They were also similar in
postpartum women with or without residual symptoms.
Although there is convincing evidence for a major role of iron
(which is required for the function of tyrosine hydroxylase in do-
pamine synthesis) in the pathophysiology of WED/RLS in non-
pregnant individuals, this relationship is not well established in
pregnant women. Disturbances in iron transport, metabolism and
storage in pregnancy might play a role in aggravating WED/RLS
symptoms in pregnant women [4,16]. However, the rapid improve-
ment in symptoms in the postpartum period is diﬃcult to account
for by changes in total iron stores, which typically remain low post-
partum [5,10]. In addition, many studies have failed to show a
difference in hemoglobin and ferritin levels between pregnant
women with and without WED/RLS [5,13]. In the present survey,
however, it was possible to demonstrate that pregnant women with
WED/RLS had signiﬁcantly lower ferritin levels, transferrin satura-
tion, and blood urea nitrogen levels. Moreover, pregnant womenwith
WED/RLS had a slightly, but signiﬁcant, higher mean gestational age
than those without, and ferritin levels showed a progressive de-
crease during pregnancy. Low ferritin levels during pregnancy were
also signiﬁcantly associated with residual WED/RLS symptoms after
delivery, supporting the ferritin hypothesis.
Another hypothesis related to the development of WED/RLS in
pregnancy involves water retention in the lower extremities sec-
ondary to increased peripheral venous distension and decreased
peripheral vascular resistance, which in turn increase the pres-
sure in the tissues surrounding the peripheral somatosensory system
receptors and thus enhance their stimulation [17]. This hypothe-
sis has not been supported by other studies [13], although in the
Ferritin (ng/mL)
(a) (b)
(c) (d)
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WED/RLS+ WED/RLS–
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40
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WED/RLS+ WED/RLS–
p=0.004
Ferritin (ng/mL)
25
30
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WED/RLS–
Residual
WED/RLS+
Residual
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p=0.008
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30
10
40
50
20
0
p=0.272
Fig. 1. Ferritin (a) and transferring saturation levels (b) in pregnant women with and without WED/RLS; ferritin (c) and transferring saturation levels (d) in postpartum
women with and without residual Willis–Ekbom disease/restless legs syndrome.
WED/RLS = Willis–Ekbom disease/restless legs syndrome; WED/RLS+ = present; WED/RLS− = absent.
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present study, the presence of varicose veins was found to be sig-
niﬁcantly more common in pregnant women with WED/RLS. A
recent study indicating a possible association between the occur-
rence of WED/RLS in pregnancy and preeclampsia may provide
indirect evidence to support this hypothesis [18].
The present study had some limitations: (1) the limited number
of women included during their ﬁrst trimester did not allow for spec-
ulation about this period of pregnancy; (2) the apparently high
numbers of pregnant women with WED/RLS – this probably oc-
curred because the participants were not consecutively recruited
and no randomizationwas used; (3) although estimation of the prev-
alence of WED/RLS was beyond the scope of this study, this ﬁnding
may attract attention to a social issue related to differences among
geographical areas in iron status and the response to iron loss.
The present survey showed that WED/RLS was more common
in the second and third trimesters, and the emergence of WED/RLS
symptoms during the second trimesterwas strongly associatedwith
residualWED/RLS after delivery. The data also conﬁrmed that later
gestational age, previous history of WED/RLS, and positive family
history were signiﬁcantly correlated with the presence of WED/
RLS in pregnancy. In addition, lower ferritin levels, transferrin
saturation, and blood urea nitrogen levels were shown to be asso-
ciatedwithWED/RLS in pregnantwomen. Lower ferritin levelswere
also associated with residual WED/RLS symptoms after delivery.
Finally, ahighernumberof pregnancieswereassociatedwithagreater
likelihood of having residual WED/RLS symptoms after delivery.
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